Literature DB >> 21801162

Drug survival rates of biologic treatments in patients with psoriasis vulgaris.

A M G Brunasso, M Puntoni, C Massone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21801162     DOI： 10.1111/j.1365-2133.2011.10557.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

Authors:  Howa Yeung; Joy Wan; Abby S Van Voorhees; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-07-28       Impact factor: 11.527

2.  Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Authors:  Richard B Warren; Catherine H Smith; Zenas Z N Yiu; Darren M Ashcroft; Jonathan N W N Barker; A David Burden; Mark Lunt; Kathleen McElhone; Anthony D Ormerod; Caroline M Owen; Nick J Reynolds; Christopher E M Griffiths
Journal:  J Invest Dermatol       Date:  2015-06-08       Impact factor: 8.551

3.  Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.

Authors:  K Callis Duffin; H Yeung; J Takeshita; G G Krueger; A D Robertson; A B Troxel; D B Shin; A S Van Voorhees; J M Gelfand
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

Review 4.  Biological therapies in moderate and severe psoriasis: perspectives and certainties.

Authors:  M M Constantin; E Poenaru; T Constantin; C Poenaru; V L Purcarea; B R Mateescu
Journal:  J Med Life       Date:  2014

5.  Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Authors:  Ireny Y K Iskandar; Richard B Warren; Mark Lunt; Kayleigh J Mason; Ian Evans; Kathleen McElhone; Catherine H Smith; Nick J Reynolds; Darren M Ashcroft; Christopher E M Griffiths
Journal:  J Invest Dermatol       Date:  2017-12-06       Impact factor: 7.590

6.  Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study.

Authors:  Christian Kromer; Dagmar Wilsmann-Theis; Sascha Gerdes; Sandra Philipp; Marthe-Lisa Schaarschmidt; Astrid Schmieder; Mohammed Dakna; Tobias Arnold; Wiebke Katharina Peitsch; Rotraut Mössner
Journal:  J Dtsch Dermatol Ges       Date:  2019-04-17       Impact factor: 5.584

7.  Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence.

Authors:  Pei-Tzu Lin; Shu-Hui Wang; Ching-Chi Chi
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.